ImmunityBio (IBRX) stock fell 7.25% to $9.27 despite ANKTIVA trial results showing a 71% response rate and lasting benefits ...
Short-Course Radiotherapy Supports Organ Preservation in Locally Advanced Rectal Cancer / locally advanced rectal cancer, ...
Global survey explores whether maintenance HER2-targeted therapy can be stopped after prolonged remission in HER2-positive ...
A new PET imaging approach detected 97.9% of lesions in clear cell renal cell carcinoma (ccRCC), potentially giving ...
ZILBRYSQ is the first and only macrocyclic peptide C5 inhibitor approved as a self-administered once-daily, subcutaneous ...
Patient’s Skin Improved from Severe to Clear with Complete Elimination of Pruritus (itch) – After 21 Months of Treatment with ...
GSK plc (LSE/NYSE: GSK) today announced the US Food and Drug Administration (FDA) has approved Jemperli (dostarlimab-gxly) as ...
Only rainwater will go into Windermere - that's the pledge from United Utilities. It has now published its 'Only Rainwater ...
A cross-sectional survey of 345 licensed Saudi community pharmacists mapped self-reported medication-adherence strategies, ...
The US Food and Drug Administration (FDA) has approved pritelivir (HOVILPRI; Asahi Kasei Therapeutics) 100-mg tablets for the ...
From anti-scorpion venom protein design to AI-engineered phage therapies, artificial intelligence-driven drug development has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results